Fungizone (amphotericin B) ORAL suspension

    Bristol-Myers Squibb is marketing Fungizone (amphotericin B) ORAL Suspension...before it was only available for IV use.

    The suspension is approved for treating oral candidiasis (thrush)...frequently seen in patients with HIV or cancer.

    It was approved by the FDA over 25 years ago, but never marketed. Now there are more cases of oral candidiasis...including infections resistant to the usual antifungals.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote